These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29295966)

  • 1. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.
    Phillips CO; Syed Y; Parthaláin NM; Zwiggelaar R; Claypole TC; Lewis KE
    J Breath Res; 2012 Sep; 6(3):036003. PubMed ID: 22759349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled breath analysis for the discrimination of asthma and chronic obstructive pulmonary disease.
    Li L; Chen H; Shi J; Chai S; Yan L; Meng D; Cai Z; Guan J; Xin Y; Zhang X; Sun W; Lu X; He M; Li Q; Yan X
    J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38834048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
    Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers.
    Basanta M; Jarvis RM; Xu Y; Blackburn G; Tal-Singer R; Woodcock A; Singh D; Goodacre R; Thomas CL; Fowler SJ
    Analyst; 2010 Feb; 135(2):315-20. PubMed ID: 20098764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for emphysema via exhaled volatile organic compounds.
    Cristescu SM; Gietema HA; Blanchet L; Kruitwagen CL; Munnik P; van Klaveren RJ; Lammers JW; Buydens L; Harren FJ; Zanen P
    J Breath Res; 2011 Dec; 5(4):046009. PubMed ID: 22071870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study.
    Basanta M; Ibrahim B; Dockry R; Douce D; Morris M; Singh D; Woodcock A; Fowler SJ
    Respir Res; 2012 Aug; 13(1):72. PubMed ID: 22916684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS.
    Das MK; Bishwal SC; Das A; Dabral D; Varshney A; Badireddy VK; Nanda R
    Anal Chem; 2014 Jan; 86(2):1229-37. PubMed ID: 24350824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human breath samples using a modified thermal desorption: gas chromatography electrospray ionization interface.
    Reynolds JC; Jimoh MA; Guallar-Hoyas C; Creaser CS; Siddiqui S; Paul Thomas CL
    J Breath Res; 2014 Sep; 8(3):037105. PubMed ID: 25190194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
    Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
    PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
    Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
    Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds.
    Basanta M; Ibrahim B; Douce D; Morris M; Woodcock A; Fowler SJ
    J Breath Res; 2012 Jun; 6(2):026002. PubMed ID: 22549110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.